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Background:  Although  intravascular  ultrasound  (IVUS)  allows  for precise  measurements  of  coronary
artery  dimension,  variability  in  quantitative  measurements  among  currently  available  different  IVUS
systems  is  unknown.  The  aim  of study  was  to  compare  two  different  IVUS  catheters  and  consoles  to
verify  their  accuracy  and  compatibility.
Methods:  (1)  In vitro  study:  IVUS  imaging  was  performed  in a  concentric  cylindrical  phantom  with  6
sections  of  known,  cross-sectional  diameter  ranging  from  3.0  to  8.0  mm.  The  minimum  lumen diameter
(MLD)  and lumen  cross  sectional  area  (CSA)  were  measured  and  compared.  (2)  In  vivo study:  IVUS  imaging
was performed  in  69  coronary  arterial  segments  from  20 patients.  The  external  elastic  membrane  cross
sectional  area  (EEM-CSA),  lumen  CSA,  and  plaque  plus  media  (P  +  M)  CSA  were  measured  and  compared
between  the  two  IVUS  systems.
Results:  (1)  In  vitro  study:  MLD  and lumen  CSA  obtained  by  the  two  IVUS  systems  correlated  well with
the actual  values.  (2)  In vivo  study:  EEM-,  lumen  and  P + M  CSA  obtained  by  the two  IVUS  systems  showed
good  correlations  (R2 =  0.973,  p <  0.0001;  R2 = 0.938,  p  < 0.0001;  R2 = 0.949,  p < 0.0001,  respectively).
Conclusions:  Quantitative  measurements  by 2 different,  currently  available  IVUS  systems  were  accurate
and comparable.  These  results  suggest  that  the  2 different  IVUS  catheters/systems  may  be alternatively
used  during  clinical  studies  assessing  coronary  arterial  size.
© 20ntroduction
Since the introduction of the intravascular ultrasound (IVUS),
ccurate measurements of the coronary vessel, lumen, and plaque
ave become available in vivo [1,2]. These quantitative measure-
ents are useful not only for device sizing during percutaneous
oronary intervention (PCI) [3,4], but also used for quantitative
ssessment of the serial changes in plaque or neointimal dimension
y various medical treatments [5–10].
Previous studies have suggested possible discrepancies between
ifferent IVUS systems [11–13].  To reliably assess serial changes
n plaque volume, formulae to adjust the differences in quantita-
ive measurements have been developed and proposed [11–13].
ecently, newer IVUS systems have been introduced and become
linically available [14–17].  The aim of this study was to assess
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accuracy and reproducibility of a recently developed IVUS system
compared with a previously validated IVUS system.
Methods
In vitro study
IVUS imaging was  performed in a concentric cylindrical phan-
tom with 6 sections of known, cross-sectional diameter ranging
from 3.0 to 8.0 mm.  Images were obtained in a saline-ﬁlled tank
maintained at 37 ◦C. Two  commercially available IVUS systems and
catheters were used in this study: a mechanical rotating 40 MHz
transducer (Atlantis Pro2, Boston Scientiﬁc Corporation, Natick, MA,
USA) and a mechanical rotating 40 MHz  transducer (ViewIt, Terumo
Corporation, Tokyo, Japan). Each ultrasound catheter from the two
systems was  inserted sequentially into the distal edge of the tube
and slowly pulled back automatically to the proximal edge.All procedures were performed by the same operator for both
systems. In each tube, 5 arbitrary segments were selected for anal-
ysis by two  independent observers. The minimum lumen diameter
(MLD) and lumen cross sectional area (CSA) were measured and
compared.
ollege of Cardiology.
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(Atlantis SR) than solid state device (InVision) [13]. Those 2 inves-
tigators proposed a calibration formula to adjust for the differences
in quantitative measurements between the 2 systems [11–13].  On
the other hand, Li et al. compared 2 similar mechanical rotating
Table 1
Patient characteristics.
Characteristics Value
Sample size 20
Age, y 68 ± 6
Male sex 13
Height, cm 158.5 ± 7.8
Weight, kg 61.1 ± 10.8
BMI  24.2 ± 2.9
Vessel (LAD/LCX/RCA) 7/6/7
Conditions
Hypertension 17 (85)
Hyperlipidemia 17 (85)
Diabetes mellitus 17 (85)
Smoking 7 (35)
Family history 8 (40)
PCI 19 (95)
CABG 0 (0)02 R. Yamada et al. / Journal o
n vivo study
Twenty patients with native coronary artery disease were
nrolled in the in vivo study. The patients underwent IVUS imag-
ng before and after PCI by both IVUS systems. Images with
 signiﬁcantly reduced quality and plaque with a calcium arc
>180◦) were excluded. Thus, 69 cross sectional images were ﬁnally
elected and measured. The interface between the plaque and
umen and the outer border of the external elastic membrane
EEM) were traced manually. On the basis of the manual tracing,
he computer software determined the following measurement
arameters: EEM-cross-sectional area (EEM-CSA), lumen CSA, and
laque plus media (P + M)  CSA [18]. This study was  in compli-
nce with the Declaration of Helsinki with regard to investigations
n humans, and the study protocol was approved by the Ethics
ommittee of Kawasaki Medical School Hospital. Written informed
onsent was obtained from all patients before cardiac catheteriza-
ion.
VUS imaging
The IVUS images were optimized under visual inspection by
anipulating the system setting provided with each device. IVUS
ullback was performed using an automated pullback device at a
ate of 0.5 mm/s. The IVUS images were continuously recorded on
D-ROM for ofﬂine analysis.
VUS analysis
The IVUS images recorded on CD-ROM were analyzed using a
ommercially available planimetry system (Echoplaque 3, INDEC
ystems, Mount View, CA, USA). In the in vivo study, coronary arter-
es with signiﬁcant stenosis (quantitative coronary angiography
75%) were selected and images of the smallest stenotic segments,
roximal edges, distal edges, proximal reference segments, and dis-
al reference segments were selected for measurement. In coronary
rteries without signiﬁcant stenosis, 5–10 arbitrary segments were
lso selected for measurement. In total, 69 pairs of IVUS images
rom the two systems were selected and stored for further analysis.
wo-dimensional longitudinal reconstruction images and short-
xis cross-sectional images were used to identify the same location
f the images. Stents, calciﬁcations and side branches were used as
andmarks to select exactly the same cross sections. The images
ere interpreted and measured by two independent well-trained
bservers at different times.
The two observers were not involved in acquiring the images
nd had no inﬂuence on the system settings.
tatistics
Statistical analysis was performed with StatView version 5.0
SAS Institute, Cary, NC, USA). Continuous variables are reported
s mean ± SD. The association between Atlantis and ViewItindices
as investigated with two different analyses: (1) linear regression
nd (2) Bland–Altman analysis of agreement. The latter analysis
as used to compare the mean difference and SD between the val-
es from Atlantis and ViewIt. The inter-observer and intra-observer
ariabilities were analyzed by linear regression. In these analyses,
 value of p < 0.05 was considered to be signiﬁcant.
esultsn vitro study
Fig. 1 shows the correlation between the values from the two
VUS systems and the actual values. Both MLD  and lumen CSAiology 61 (2013) 201–205
obtained by the two IVUS systems correlated well with the actual
values.
Fig. 2 shows the correlation between the values from Atlantis
and ViewIt. Both MLD  and lumen CSA obtained by the two IVUS
systems have a good correlation.
In vivo study
Table 1 shows the patient characteristics in this study. Fig. 3
shows the correlation between the values obtained from Atlantis
and ViewIt. EEM-CSA, lumen CSA, and P + M CSA obtained by the
two IVUS systems showed good correlations.
Inter-observer and intra-observer variability
Among all the in vivo and in vitro measured values, there were
no statistical differences between the two  observers. Intra-observer
variability for in vivo EEM CSA and lumen CSA measurements were
3.1 ± 5.1% and 3.1 ± 4.9%, respectively. Inter-observer variability for
in vivo EEM-CSA and lumen CSA measurements were 4.2 ± 5.3% and
4.4 ± 5.2%, respectively.
Discussion
Our present study demonstrated that a newer generation IVUS
system provides accurate quantitative measurements comparable
to a previously developed and validated IVUS system.
Since the introduction of the commercially available IVUS sys-
tems, several IVUS systems have been developed and been sold on
the market. Although each IVUS system validated its accuracy in
quantitative measurement of the coronary vessel in vitro, several
studies have suggested some discrepancies between different IVUS
systems [11–13].
Schoenhagen et al. compared between 40 MHz  mechanical scan-
ner IVUS catheter system (Atlantis SR/Ultracross, Boston Scientiﬁc)
and 20 MHz  phased array IVUS catheter system (InVision/Avanar,
Volcano, Rancho Cordova, CA, USA) in an in vitro cylindric phan-
tom model and demonstrated up to 18% differences in quantitative
results between the 2 systems [11]. Similarly, Hartmann et al. have
shown, in an ex vivo human coronary artery, that P + M CSA as well
as plaque burden were signiﬁcantly larger in mechanical deviceData are presented as no. (%) or mean ± SD, unless otherwise indicated.
BMI, body mass index; LAD, left anterior descending artery; LCX, left circumﬂex
artery; RCA, right coronary artery; PCI, percutaneous coronary intervention; CABG,
coronary artery bypass graft surgery.
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Fig. 1. Correlation between the values from two intravascular ultrasound systems and the actual values (in vitro study). Left upper panel: MLD  by Atlantis Pro (Boston
Scientiﬁc Corporation, Natick, MA,  USA) vs. actual value; Right upper panel: MLD  by ViewIt (Terumo, Tokyo, Japan) vs. actual value; Left lower panel: lumen CSA by Atlantis
Pro  vs. actual value; Right lower panel: lumen CSA by ViewIt vs. actual value. MLD, minimum lumen diameter; CSA, cross-sectional area.
Fig. 2. Correlation between MLD  (left panel) and lumen CSA (right panel) obtained by Atlantis Pro (Boston Scientiﬁc Corporation, Natick, MA,  USA) vs. ViewIt (Terumo, Tokyo,
Japan)(in vitro study). MLD, minimum lumen diameter; CSA, cross-sectional area.
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pig. 3. Correlation of EEM CSA (left panel), lumen CSA (middle panel) and P + M CSA
iewIt  (Terumo, Tokyo, Japan) (in vivo study). EEM, elastic external membrane; CSA
VUS systems (40 MHz  Atlantis and 35 MHz  Intrafocus, Terumo), in
n in vitro cylindric phantom model and demonstrated that lumen
iameter and lumen area by Intrafocus was signiﬁcantly smaller
han those obtained by Atlantis [12]. In addition, their in vivo study
imilarly demonstrated that lumen diameter, lumen CSA, P + M,  CSA
nd EEM CSA obtained by Intrafocus were consistently smaller than
hose obtained by Atlantis [12]. The main cause of these discrep-
ncies was a difference in the speed of ultrasound used in both
ystems [12]. The speed of ultrasound was 1562 m/s  in Atlantis and
530 m/s  in Intrafocus.
Furthermore, differences in the frequency of transducer (InVi-
ion: 20 MHz, Intrafocus: 35 MHz, Atlantis: 40 MHz) might have
ontributed to the differences in quantitative measurements
ecause an ultrasound transducer with higher frequency usually
as better resolution.
The 2nd generation IVUS catheter and system (ViewIt and Visi-
ave, Terumo) used the speed of sound similar to the Atlantis
1562 m/s). As a result, these 2 systems showed similarity with
espect to the quantitative measurements in our present study.
herefore, these 2 different IVUS systems may  be alternatively used
o assess serial changes in neointimal volume or natural course of
he coronary plaque volume progression or regression in clinical
tudies.
Although our present study demonstrated the similarity
etween the 2 IVUS systems, these results cannot be generalized to
ther commercially available IVUS catheters with different ultra-
ound frequency [19].
In addition, a few overestimations and underestimations in EEM
nd lumen CSA measurements are observed in vivo. Such differ-
nces might be caused by artifacts such as non-uniform rotational
istortion during IVUS pullback in tortuous lesions.
In conclusion, a recently developed newer IVUS system
rovides accurate and comparable 2 dimensional quantitative panel) obtained from Atlantis (Boston Scientiﬁc Corporation, Natick, MA,  USA) and
s-sectional area; P + M,  plaque plus media.
measurements as compared with a previously validated
IVUS catheter and system. Therefore, these 2 different IVUS
catheters/systems may  be alternatively used during clinical
studies assessing coronary arterial dimensions.
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